Sunshine Biopharma advances mRNA cancer vaccine strategy for lung cancer
SBFM says its in vivo work shows tumor suppression with K1.1 mRNA and it is advancing a novel mRNA vaccine strategy for lung cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sunshine Biopharma advances K1.1 mRNA cancer-vaccine strategy
Sunshine Biopharma says it has reported in vivo tumor suppression with K1.1 mRNA and advanced a novel mRNA-cancer vaccine strategy for lung cancer.